View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by Haselmeier

D-Flex® Injection Pen for GLP-1 Medication

Free White Paper

D-Flex® Injection Pen for GLP-1 Medication

By Haselmeier

D-Flex® Injection Pen for GLP-1 Medication

By Haselmeier
Enter your details to receive the free paper:

Type 2 diabetes is a global health problem. According to expert estimates, the number of patients worldwide will increase by 48% by 2045.

Constantly elevated blood sugar levels mean stress for the blood vessels, which can lead to feared complications, including life-threatening sequelae such as a heart attack, organ failure or stroke.

A consistent treatment of Type 2 diabetes as early as possible can significantly improve the quality of life for the patient and the course of the disease.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology